SHENZHEN, China, Aug. 19, 2024 /PRNewswire/ — UTime Limited (NASDAQ: WTO) (“UTime” or “the Company”) is excited to announce a groundbreaking Memorandum of Understanding (MOU) with XCardio, a leading Japanese enterprise spearheaded by the esteemed Dr. Ehud Baron, a prominent figure in medical technology innovation. This strategic alliance is set to focus on the joint development of BPWatch, a cutting-edge continuous blood pressure monitoring device, aimed at significantly advancing the management of cardiovascular diseases.
This visionary collaboration intends to transform UTime’s business model from selling BP watches directly to consumers at low margins to adopting a high-margin, recurring revenue stream through a Per Patient Per Month (PPPM) payment structure. The initiative aims to facilitate the deployment of high-margin systems that can revolutionize patient monitoring and care delivery.
Dr. Ehud Baron infuses the partnership with his deep expertise in blood pressure management, hemodynamics, health mapping, and AI-driven diagnostics. His involvement underscores UTime’s renewed commitment to enhancing health and wellness through state-of-the-art medical wearable technology. Leveraging strategic collaborations and pioneering research, UTime is dedicated to delivering impactful global solutions for disease prevention and health management.
Dr. Baron boasts a prestigious background as a former professor at the Israel Institute of Technology, UC Berkeley, and Stanford University. Additionally, he has successfully founded and managed several companies within the cardiology, sleep, and AI sectors, further underscoring his profound expertise in these fields.
In the wake of the heightened global need for health and disease prevention, especially following the 2019 COVID-19 pandemic, UTime has redoubled its efforts in the realm of advanced medical wearables. The 2024 partnership between UTime and Dr. Ehud Baron is focused on the development of an innovative blood pressure monitoring watch, leveraging Dr. Baron’s proprietary continuous blood pressure measurement technology. This collaboration is anticipated to be instrumental in propelling UTime’s initiatives in blood pressure monitoring solutions. Looking ahead, UTime is committed to broadening its portfolio of medical wearable products, harnessing Dr. Baron’s expertise to meet the accelerating global demand for advanced health technologies.
About UTime Limited
Founded in 2008, UTime Ltd. is dedicated to providing cost-effective mobile devices to consumers around the world, ensuring that updated mobile technology is accessible to low-income individuals in both established markets, like the United States, and emerging markets, including countries in South Asia and Africa. Since 2024, UTime has focused on revolutionizing health and wellness through innovative medical wearable technologies. Drawing on cutting-edge research and strategic partnerships, UTime aims to deliver effective health management and disease prevention solutions on a global scale. For more information, visit the company’s website at http://www.utimeworld.com/.
Forward-Looking Statements
Statements in this press release regarding future expectations, plans, and prospects—along with any other statements that are not historical facts—may be considered “forward-looking statements” as defined in The Private Securities Litigation Reform Act of 1995. These statements may include, but are not limited to, UTime’s ability to achieve compliance with Nasdaq’s continued listing requirements. Terms like “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and similar expressions are used to identify forward-looking statements, although not all forward-looking statements contain such words. Actual outcomes may vary significantly from those predicted due to various important factors enumerated in the “Risk Factors” section of the Annual Report in Form 20-F filed with the SEC on July 30, 2024. Forward-looking statements herein are valid only as of the date of this release, and the Company does not undertake any responsibility to update them as a result of new information or future events.
For further information, please contact:
Eaky Tan
eaky@westock.com
View original content: https://www.prnewswire.com/news-releases/utime-limited-partners-with-dr-ehud-baron-to-pioneer-ai-driven-health-solutions-302225098.html
SOURCE UTime Limited